摘要

Over the last decade, array-based methods for the detection of genomic imbalances have gained increasing importance in the field of cancer genetics. With their particular platform-specific advantages and disadvantages, different array comparative genomic hybridization (CGH) and single nucleotide polymorphism (SNP) array-based technologies can be utilized according to the question addressed, the material to be analyzed and the resolution targeted. In contrast to array CGH-based technologies, SNP-based arrays allow the simultaneous detection of copy-neutral loss of heterozygosity in addition to the diagnosis of chromosomal imbalances. In all array-based approaches it should be borne in mind that tumors are usually a mixture of clonal neoplastic and normal cells and that some aberrations might be subclonal. Applications of array-based imbalance mapping in cancer include the characterization of pathogenetically relevant imbalances, the definition of molecular or clinical subgroups of tumors or the identification of targets for individualized therapy.

  • 出版日期2012-6

全文